Pooled ShRNA Screenings: Computational Analysis
Genome-wide RNA interference screening has emerged as a powerful tool for functional genomic studies of disease-related phenotypes and the discovery of molecular therapeutic targets for human diseases. Commercial short hairpin RNA (shRNA) libraries are commonly used in this area, and state-of-the-art technologies including microarray and next-generation sequencing have emerged as powerful methods to analyze shRNA-triggered phenotypes. However, computational analysis of this complex data remains challenging due to noise and small sample size from such large-scaled experiments. In this chapter we discuss the pipelines and statistical methods of processing, quality assessment, and post-analysis for both microarray- and sequencing-based screening data.
- c-erbB-2 Immunohistochemistry in Paraffin Tumors
- Measurements of Phospholipases A2, C, and D (PLA2, PLC, and PLD): In Vitro Microassays, Analysis of Enzyme Isoforms, and Intact-
- Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens
- Designing Plasmid Vectors
- Targeted Alpha Therapy of Prostate Cancer
- Isolation of Inflammatory Cells from Human Tumours
- Silencing Epidermal Growth Factor Receptor by RNA Interference in Glioma
- TGF-Beta,FN酶联免疫(ELISA)试剂盒的选择
- 四唑盐(MTT)比色法
- 同一种细胞,不同质粒转染,那G418筛选浓度都一样吗